Literature DB >> 31105266

Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.

Elena M Cornejo Castro1, Brian J Morrison1, Vickie A Marshall1, Nazzarena Labo1, Wendell J Miley1, Nathan Clements1, George Nelson2,3, Paul Ndom4, Kristen Stolka5, Jennifer J Hemingway-Foday5, Mahamat Abassora4, Xiaojiang Gao6, Jennifer S Smith7, Mary Carrington6,8, Denise Whitby9.   

Abstract

Several studies published to date report associations between human leukocyte antigen (HLA) alleles and different types of Kaposi's Sarcoma (KS). However, there is little concordance between the HLA alleles identified and the populations studied. To test whether HLA alleles associate with KS in a Cameroonian case-control study, we performed high-resolution HLA typing in KSHV seropositive individuals. Among HIV-positive individuals, carriers of HLA-B*14:01 were at a significantly higher risk of AIDS-KS (p = 0.033). For HIV-negative patients, a gene-wise comparison of allele frequencies identified the HLA-B (p = 0.008) and -DQA1 (p = 0.002) loci as possible risk factors for endemic KS. Our study provides additional understanding of genetic determinants of KS and their implications in disease pathogenesis. Further validation of these findings is needed to define the functional relevance of these associations.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31105266      PMCID: PMC6864225          DOI: 10.1038/s41435-019-0077-9

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  40 in total

1.  Monte Carlo tests for associations between disease and alleles at highly polymorphic loci.

Authors:  P C Sham; D Curtis
Journal:  Ann Hum Genet       Date:  1995-01       Impact factor: 1.670

2.  HLA and Kaposi's sarcoma in Sardinia.

Authors:  L Contu; D Cerimele; A Pintus; F Cottoni; G La Nasa
Journal:  Tissue Antigens       Date:  1984-04

3.  A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.

Authors:  Elizabeth E Brown; M Daniele Fallin; James J Goedert; Renee Chen; Denise Whitby; Charles B Foster; Carmela Lauria; Anthony J Alberg; Angelo Messina; Mauizio Montella; Giovanni Rezza; Francesco Vitale; Stephen J Chanock
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-03       Impact factor: 4.254

4.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

5.  Clinical features of Kaposi's sarcoma in Croatian renal transplant recipients.

Authors:  Lj Bubic-Filipi; N Basić-Jukić; J Pasini; Z Kastelan; P Kes
Journal:  Prilozi       Date:  2009-12

6.  HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.

Authors:  H E Prince; R W Schroff; G Ayoub; S Han; M S Gottlieb; J L Fahey
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

7.  Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients.

Authors:  Amgad E El-Agroudy; Mahmoud A El-Baz; Amani M Ismail; Bedeir Ali-El-Dein; Ahmed B Shehab El-Dein; Mohamed A Ghoneim
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

8.  Activating KIR/HLA complexes in classic Kaposi's Sarcoma.

Authors:  Franca R Guerini; Roberta Mancuso; Simone Agostini; Cristina Agliardi; Milena Zanzottera; Ambra Hernis; Athanasia Tourlaki; Maria G Calvo; Monica Bellinvia; Lucia Brambilla; Mario Clerici
Journal:  Infect Agent Cancer       Date:  2012-04-02       Impact factor: 2.965

9.  T-cell responses to KSHV infection: a systematic approach.

Authors:  Romin Roshan; Nazzarena Labo; Matthew Trivett; Wendell Miley; Vickie Marshall; Lori Coren; Elena M Cornejo Castro; Hannah Perez; Benjamin Holdridge; Eliza Davis; Rodrigo Matus-Nicodemos; Victor I Ayala; Raymond Sowder; Kathleen M Wyvill; Karen Aleman; Christine Fennessey; Jeffrey Lifson; Mark N Polizzotto; Daniel Douek; Brandon Keele; Thomas S Uldrick; Robert Yarchoan; Claes Ohlen; David Ott; Denise Whitby
Journal:  Oncotarget       Date:  2017-11-25

10.  Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.

Authors:  Mhairi Maskew; Matthew P Fox; Gilles van Cutsem; Kathryn Chu; Patrick Macphail; Andrew Boulle; Matthias Egger; For Iedea Southern Africa
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

View more
  3 in total

1.  The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.

Authors:  Christina Ekenberg; Joanne Reekie; Adrian G Zucco; Daniel D Murray; Shweta Sharma; Cameron R Macpherson; Abdel Babiker; Virginia Kan; H Clifford Lane; James D Neaton; Jens D Lundgren
Journal:  AIDS       Date:  2021-04-01       Impact factor: 4.632

2.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

Review 3.  Evidence for altered host genetic factors in KSHV infection and KSHV-related disease development.

Authors:  Melissa J Blumenthal; Elena Maria Cornejo Castro; Denise Whitby; Arieh A Katz; Georgia Schäfer
Journal:  Rev Med Virol       Date:  2020-10-11       Impact factor: 6.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.